Cognitive or Cognitive-Motor Executive Function Tasks? Evaluating Verbal Fluency Measures in People with Parkinson's Disease

Carregando...
Imagem de Miniatura
Citações na Scopus
22
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
HINDAWI LTD
Citação
BIOMED RESEARCH INTERNATIONAL, article ID 7893975, 7p, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction. Executive function deficits are observed in people with Parkinson's disease (PD) from early stages and have great impact on daily living activities. Verbal fluency and oral diadochokinesia involve phonarticulatory coordination, response inhibition, and phonological processing and may also be affected in people with PD. This study aimed to describe the performance of PD patients and an age-and education-matched control group on executive function, verbal fluency, and oral diadochokinesia tests and to investigate possible relationships between them. Methods. Forty people with PD and forty controls were evaluated with Trail Making Test (TMT, executive function) and phonemic/semantic verbal fluency and oral diadochokinesia (/pataka/) tests. Groups were compared by ANOVA and relationships were investigated by Pearson tests. Results. People with PD showed longer times in parts A and B of TMT. They also said fewer words in phonemic/semantic verbal fluency tests and less syllables in the diadochokinesia test. Oral diadochokinesia strongly correlated to parts A and B of TMT and to phonemic verbal fluency. Conclusion. Oral diadochokinesia was correlated to executive function and verbal fluency. The cognitive-motor interaction in verbal fluency and oral diadochokinesia must be considered not to overestimate the cognitive or motor impairments in people with PD.
Palavras-chave
Referências
  1. Amboni M, 2013, MOVEMENT DISORD, V28, P1520, DOI 10.1002/mds.25674
  2. Barbosa AF, 2015, ARQ NEURO-PSIQUIAT, V73, P906, DOI 10.1590/0004-282X20150153
  3. Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001
  4. Biundo R, 2014, PARKINSONISM RELAT D, V20, P394, DOI 10.1016/j.parkreldis.2014.01.009
  5. Bohnen NI, 2015, JAMA NEUROL, V72, P194, DOI 10.1001/jamaneurol.2014.2757
  6. Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390
  7. Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014
  8. Ellfolk U, 2014, J NEURAL TRANSM, V121, P33, DOI 10.1007/s00702-013-1073-2
  9. Gurd JM, 2000, J NEUROLINGUIST, V13, P47, DOI 10.1016/S0911-6044(99)00011-1
  10. Hanna-Pladdy B, 2007, J Neurol Phys Ther, V31, P119
  11. Higginson CI, 2013, J CLIN EXP NEUROPSYC, V35, P530, DOI 10.1080/13803395.2013.798397
  12. Hoehn MM, 2001, NEUROLOGY, V57, pS11
  13. Ketteler S, 2014, BRAIN RES, V1581, P51, DOI 10.1016/j.brainres.2014.06.030
  14. Lezak M. D., 2004, NEUROPSYCHOLOGICAL A
  15. Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823
  16. Marchese R, 2003, MOVEMENT DISORD, V18, P652, DOI 10.1002/mds.10418
  17. Martins Vanessa de Oliveira, 2008, Pró-Fono R. Atual. Cient., V20, P7, DOI 10.1590/S0104-56872008000100002
  18. McDowd J, 2011, NEUROPSYCHOLOGY, V25, P210, DOI 10.1037/a0021531
  19. Metman LV, 2004, MOVEMENT DISORD, V19, P1079, DOI 10.1002/mds.20101
  20. Monchi O, 2007, BRAIN, V130, P233, DOI 10.1093/brain/awl326
  21. Mukaka M., 2012, J MALAWI MEDICAL, V24, P69, DOI 10.1016/J.CMPB.2016.01.020
  22. Owen AM, 2004, NEUROSCIENTIST, V10, P525, DOI 10.1177/1073858404266776
  23. Padovani M, 2009, ARQ NEURO-PSIQUIAT, V67, P58, DOI 10.1590/S0004-282X2009000100015
  24. Ranchet M, 2012, EUR NEUROL, V68, P98, DOI 10.1159/000338264
  25. Rodrigues IT, 2015, ARQ NEURO-PSIQUIAT, V73, P520, DOI 10.1590/0004-282X20150056
  26. Shapiro KA, 2005, NEUROIMAGE, V24, P1058, DOI 10.1016/j.neuroimage.2004.10.015
  27. Souza CD, 2013, COGN BEHAV NEUROL, V26, P6, DOI 10.1097/WNN.0b013e31828c5956
  28. Strouwen C, 2016, PARKINSONISM RELAT D, V23, P23, DOI 10.1016/j.parkreldis.2015.11.020
  29. Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2
  30. Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8
  31. Varalta V, 2015, BIOMED RES INT, DOI 10.1155/2015/365959
  32. Wylie SA, 2009, NEUROPSYCHOLOGIA, V47, P1844, DOI 10.1016/j.neuropsychologia.2009.02.025
  33. Zarino B, 2014, NEUROL SCI, V35, P1405, DOI 10.1007/s10072-014-1729-1